(Seul le prononcé fait foi)
Ladies and gentlemen,
Thank you for your invitation. I will do what a French minister is not supposed to do here in the United Nations, meaning to speak English.
One key word of our meeting is innovation. Innovation in models for development, in financing schemes, in governance. In politics, you are right to say that we are usually told "well it does not exist, it will not work". And we together brought innovation in the field of development, and we can be proud of it.
France is implementing various innovating tools, notably in the field of health :
Thanks to the international solidarity levy on airline tickets and the emission of immunisation bonds, France has become the second financing country of the Global Fund, the fourth institutional donor to GAVI and the leading contributor to UNITAID (International drug purchasing facility). Last year, we decided to allocate 10% of a financial transaction tax (FTT) to development, and it will be raised to 15% in 2014. In 2014 we will also increase by 12% our solidarity levy on airline tickets.
There is no need to recall the impressive results brought about by GAVI, the Global Fund and others such as UNITAID. They have not only saved millions of lives but they have also unleashed major sources of development, by preserving the workforce
I wish to draw three lessons of Gavi global fund and Unitaid
At the financial level, the matching fund initiative used by GAVI, for instance, has shown how the public and private sector can encourage each other in order to donate more.
At the governance level, they are open on civil society through consultation procedures and country level dialogue on one hand. And, on the other hand, include, for some of them such as GAVI and the Global Fund, members of civil society, government actors and the private sector in their decision-making processes, within their boards and at country level.
At the operational level, they changed the dynamics. UNITAID has for example had a strong action in shaping markets in order to reduce the price of drugs and facilitate access to patents thanks to deep and pragmatic relationships with pharmaceutical companies.
I also would like to stress that at these three levels : financial, governance and operationnal, they increase transparency.
I strongly believe that the originality and efficiency of the Global Public-Private Partnerships in health have set a precedent which can be replicated in other fields of development. In the field of climate change for example
Innovative financing mechanisms are diverse and new ideas are emerging in many development fields. Canada and Australia have for example recently presented to the G20 proposals of pull-mechanisms aimed at lowering remittances costs. If G20 countries succeeded in lowering remittance costs to 5%, as it was agreed at the Cannes Summit, it would deliver an additional US$20 billion each year to developing countries.
We ought to pursue on this path, with a wider range of partner countries, in order to maintain and widen the incredible results reached so far.